1. Dynamics of lipid profile, lipoprotein (a) and HBA1C after one year of evolocumab. (August 2021) Authors: Ranasinghe, R.N.; Mazaheri, T.; Alhasani, W.; Chandra, R.; Vincent, R.P.; Rao, N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipoprotein (a) in stratifying risk of cardiovascular disease in a multi-ethnic cohort. (August 2021) Authors: Mazaheri, T.; Ranasinghe, R.N.; Alhasani, W.; Vincent, R.P.; Rao, N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Non-HDL cholesterol and body mass index in patients with phenotypic characteristics of familial hypercholesterolemia. (December 2020) Authors: Ranasinghe, R.N.; Kyaw, W.W.; Ansari, S.; Chandra, R.; Vincent, R.P.; Rao, N. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Routine use of Fribrosis-4 index in lipid clinic. (August 2022) Authors: Mazaheri, T.; Ranasinghe, R.N.; Jennings, A.; Alhasani, W.; Rao, N.; Dimitriadis, G.K.; Vincent, R.P. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗